Literature DB >> 15925254

Application of a novel ultra-low elution volume 96-well solid-phase extraction method to the LC/MS/MS determination of simvastatin and simvastatin acid in human plasma.

Amy Y Yang1, Li Sun, Donald G Musson, Jamie J Zhao.   

Abstract

A novel extraction method has been utilized in the LC/MS/MS determination of simvastatin and simvastatin acid in human plasma. In this method, 300 microl of plasma sample was loaded onto a Waters Oasis 96-well HLB microElution plate, the stationary phase was washed using 2 x 400 microl of 5% methanol in water, and the analytes were eluted using 35 microl of 95/5 acetonitrile/H(2)O twice. The sample extracts were diluted with 40 microl of methyl ammonium acetate (1mM, pH 4.5). Chromatography was performed on a Phenomenex Synergi Max-RP column (2.0 mm x 50 mm, 4 microm). A PE Sciex API 3000 tandem mass spectrometer interfaced with a turbo ionspray source was used for mass detection. Compared to solid-phase extraction, liquid-liquid extraction and solid-supported liquid-liquid extraction methods that were developed and previously used in our laboratory, this method reduced the labor cost and was less time consuming in sample preparation, due to the fact that post-extraction solvent evaporation and reconstitution steps were avoided using this microElution solid-phase extraction plate. The method has been proved to be fast, reliable and reproducible.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15925254     DOI: 10.1016/j.jpba.2005.01.016

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

1.  Experimental nonalcoholic steatohepatitis increases exposure to simvastatin hydroxy acid by decreasing hepatic organic anion transporting polypeptide expression.

Authors:  John D Clarke; Rhiannon N Hardwick; April D Lake; Mark J Canet; Nathan J Cherrington
Journal:  J Pharmacol Exp Ther       Date:  2014-01-08       Impact factor: 4.030

2.  Clinical relevance of liquid chromatography tandem mass spectrometry as an analytical method in microdose clinical studies.

Authors:  Naoe Yamane; Zenzaburo Tozuka; Makiko Kusama; Kazuya Maeda; Toshihiko Ikeda; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2011-04-07       Impact factor: 4.200

3.  A Simple Protein Precipitation-based Simultaneous Quantification of Lovastatin and Its Active Metabolite Lovastatin Acid in Human Plasma by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry using Polarity Switching.

Authors:  Ju Wujian; Peng Kuan-Wei; Yang Sihyung; Sun Huijing; Sampson Mario; Wang Michael Zhuo
Journal:  J Chromatogr Sep Tech       Date:  2015-05

4.  Method Validation for Analysis of Simvastatin in Human Plasma Using Liquid Chromatography Tandem Mass Spectrometry (LC-MS-MS).

Authors:  Khaled M Alakhali
Journal:  J Clin Diagn Res       Date:  2013-12-15

5.  Synthesis, characterization and quantification of simvastatin metabolites and impurities.

Authors:  Manish S Bhatia; Swapnil D Jadhav; Neela M Bhatia; Prafulla B Choudhari; Kundan B Ingale
Journal:  Sci Pharm       Date:  2011-07-25

6.  Comparison of conventional and supported liquid extraction methods for the determination of sitagliptin and simvastatin in rat plasma by LC-ESI-MS/MS.

Authors:  B Ramesh; N Manjula; S R Bijargi; V U M Sarma; P Sita Devi
Journal:  J Pharm Anal       Date:  2014-12-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.